FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this trial is to assess dose related safety, efficacy, and pharmacokinetics (PK) of INT-787 in participants with severe alcohol-associated hepatitis (sAH).
Epistemonikos ID: 627cee6fc68112c51e610bba0c5a92d449bd48f0
First added on: May 14, 2024